Alcon Shares Outstanding 2019-2022 | ALC

Alcon shares outstanding history from 2019 to 2022. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Alcon shares outstanding for the quarter ending September 30, 2022 were 0.495B, a 0.18% increase year-over-year.
  • Alcon 2021 shares outstanding were 0.493B, a 0.9% increase from 2020.
  • Alcon 2020 shares outstanding were 0.489B, a 0.16% increase from 2019.
  • Alcon 2019 shares outstanding were 0.488B, a 0% decline from 2018.
Alcon Annual Shares Outstanding
(Millions of Shares)
2021 493
2020 489
2019 488
2018 488
Alcon Quarterly Shares Outstanding
(Millions of Shares)
2022-09-30 495
2022-06-30 494
2022-03-31 494
2021-12-31 493
2021-09-30 494
2021-06-30 493
2021-03-31 493
2020-12-31 489
2020-09-30 489
2020-06-30 489
2020-03-31 489
2019-12-31 488
2019-09-30 488
2019-06-30 488
2019-03-31 488
2018-12-31
2018-09-30 488
2018-06-30 488
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $37.369B $8.291B
Alcon Inc. researches, develops, manufactures, distributes, and sells a full suite of eye care products. Alcon operates within two segments, Surgical and Vision Care. The Surgical segment is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery, and includes implantables, consumables, and surgical equipment required for these procedures. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, and a comprehensive portfolio of ocular health products, including products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $230.517B 25.29
Edwards Lifesciences (EW) United States $50.772B 33.11
STERIS (STE) Ireland $21.864B 27.21
Teleflex (TFX) United States $12.124B 19.67
Fresenius Medical Care AG KGaA (FMS) Germany $11.123B 11.16
Penumbra (PEN) United States $9.913B 2372.91
Globus Medical (GMED) United States $7.951B 40.42
Glaukos (GKOS) United States $2.458B 0.00
Integer Holdings (ITGR) United States $2.435B 19.55
AVANOS MEDICAL, INC (AVNS) United States $1.469B 20.92
Nevro (NVRO) United States $1.410B 0.00
Paragon 28 (FNA) United States $1.346B 0.00
Artivion (AORT) United States $0.566B 0.00